Obese Patients With Untreated Dyslipidemias
RIO-Lipids
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study of Weight-Reducing Effect and Safety in Obese Patients With Untreated Dyslipidemias
1 other identifier
interventional
1,033
8 countries
35
Brief Summary
To assess the effect on weight loss and weight maintenance over a period of one year when prescribed with a hypocaloric diet in obese patients with untreated dyslipidemia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3 obesity
Started Sep 2001
35 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2001
CompletedFirst Submitted
Initial submission to the registry
January 23, 2002
CompletedFirst Posted
Study publicly available on registry
January 24, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2003
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2003
CompletedApril 20, 2009
April 1, 2009
2.2 years
January 23, 2002
April 17, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline in body weight at 1 year.
Secondary Outcomes (1)
Metabolic parameters
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Sanofilead
Study Sites (35)
Clinic of Physicians and Surgeons, LTD
Mesa, Arizona, 85201, United States
Arizona Clinical Research Center, Inc.
Tucson, Arizona, 85712, United States
Irvine Center for Clinical Research (ICCR)
Irvine, California, 92618, United States
Los Angeles Clinical Trials
Los Angeles, California, 90064, United States
Apexute
Santa Ana, California, 92705, United States
Clinical Research of South Florida
Coral Gables, Florida, 33134, United States
Radiant Research
Stuart, Florida, 34996, United States
nTouch Research
Peoria, Illinois, 61602, United States
nTouch Research
South Bend, Indiana, 46601, United States
Bluegrass Clinical Research, Inc.
Louisville, Kentucky, 40291, United States
Johns Hopkins Women's Research Core
Lutherville, Maryland, 21093, United States
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
Twin Cities Clinical Research
Arden Hills, Minnesota, 55126, United States
Radiant Research
Edina, Minnesota, 55435, United States
Women's Clinic of Lincoln, PC
Lincoln, Nebraska, 68510, United States
New Mexico Clinical Research & Osteoporosis Center, Inc.
Albuquerque, New Mexico, 87106, United States
Clinical Research Services
Bismarck, North Dakota, 58501, United States
University of Cincinnati College of Medicine
Cincinnati, Ohio, 45267-0559, United States
Altoona Center for Clinical Research
Duncansville, Pennsylvania, 16635, United States
Clinical Research Division
Newtown, Pennsylvania, 18940, United States
Clinical Research Center of Reading, LLC
West Reading, Pennsylvania, 19611-1124, United States
Medical University of South Carolina, Division of Clinical Pharmacology
Charleston, South Carolina, 29425, United States
Nashville Medical Research Institute
Nashville, Tennessee, 37205, United States
Radiant Research
Salt Lake City, Utah, 84111, United States
Clinical Research Center of Northern Virginia
Falls Church, Virginia, 22044, United States
Hunter Holmes McGuire Medical Center Research Service (151)
Richmond, Virginia, 23249, United States
Vancouver Medical Weight Loss Clinic
Vancouver, Washington, 98685, United States
Addiction & Psychiatric Medicine Research
Morgantown, West Virginia, 26506-9300, United States
Sanofi-aventis Administrative Office
Macquarie Park, Australia
Sanofi-aventis Administrative Office
Laval, Canada
Sanofi-aventis Administrative Office
Helsinki, Finland
Sanofi-aventis Administrative Office
Milan, Italy
Sanofi-aventis Administrative Office
Barcelona, Spain
Sanofi-aventis Administrative Office
Bromma, Sweden
Sanofi-aventis Administrative Office
Geneva, Switzerland
Related Publications (1)
Despres JP, Golay A, Sjostrom L; Rimonabant in Obesity-Lipids Study Group. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med. 2005 Nov 17;353(20):2121-34. doi: 10.1056/NEJMoa044537.
PMID: 16291982RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ICD CSD
Sanofi
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
January 23, 2002
First Posted
January 24, 2002
Study Start
September 1, 2001
Primary Completion
November 1, 2003
Study Completion
November 1, 2003
Last Updated
April 20, 2009
Record last verified: 2009-04